Table 1 Whole-exome sequencing mutation data analyzed in this study
Patient characteristics | TCGA | Matthew [5] | Rizvi [4] |
|---|---|---|---|
No. (%) | No. (%) | No. (%) | |
Histology | |||
 Adenocarcinoma | 486 | 59 | 29 |
Age (years) | |||
 No less than 65 | 223 (46) | 29 (50) | 10 (34) |
 Less than 65 | 263 (54) | 30 (50) | 19 (66) |
Sex | |||
 Male | 222 (46) | 22 (37) | 13 (45) |
 Female | 264 (54) | 37 (63) | 16 (55) |
Smoking status | |||
 Never | – | 13 (22) | 5 (17) |
 Former/light | – | 38 (64) | 18 (62) |
 Current/heavy | – | 8 (14) | 6 (21) |
Stage | |||
 I | 263 (54) | – | – |
 II | 117 (24) | – | – |
 IIIA | 70 (14) | – | – |
 IIIB–IV | 36 (7) | 59 (100) | 29 (100) |
PFS-status | |||
 Progression | – | 40 (68) | 20 (69) |
 Progression-free | – | 19 (32) | 9 (31) |
Percentage of tumour cells | |||
 Known | 433 (89) | – | – |
 Unknown | 53 (11) | – | – |
Average percentage of tumour cells | 78.76 | – | – |